New Haven Pharmaceuticals Lands $6,490,773 New Funding

  • Feed Type
  • Date
    10/4/2012
  • Company Name
    New Haven Pharmaceuticals
  • Mailing Address
    142 Temple Street New Haven, CT 06510
  • Company Description
    New Haven Pharmaceuticals, Inc. (NHP) develops proprietary, controlled release specialty pharmaceuticals based on approved or GRAS active pharmaceutical ingredients for use in new therapeutic indications. NHP’s novel product pipeline is built on three licenses from Yale University and Micropump Aspirin, the world’s only 24-hour controlled-release aspirin, licensed from Flamel Technologies.
  • Website
    http://www.newhavenpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,490,773
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.